Mergers & Acquisitions


Current filters:


Popular Filters

776 to 800 of 924 results

Walgreen to take 45% stake in Alliance Boots for $6.7 billion


US drugstore chain Walgreen (NYSE: WAG) has agreed to acquire a 45% holding in pharmacy, health and beauty…

Alliance BootsMergers & AcquisitionsPharmaceuticalWalgreen

Valeant goes shopping again, this time for OraPharma


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) said Friday that it has…

FinancialMergers & AcquisitionsOraPharmaPharmaceuticalValeant Pharmaceuticals

Human Genome Sciences sets July 16 deadline for takeover bids


In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Pharming considers options, including a sale of the company


Netherland-based biotech company Pharming Group (NYSE Euronext: PHARM) yesterday revealed that it is…

BiotechnologyLicensingMergers & AcquisitionsPharmingRare diseasesResearchRuconest

Lilly to increase equity position in China's Novast by $20 million


US pharma major Eli Lilly (NYSE: LLY) says it will increase of its network of manufacturing capabilities…

Asia-PacificEli LillyGenericsMergers & AcquisitionsNovast LaboratoriesPharmaceutical

US regulator puts conditions on Johnson & Johnson's proposed buy of Synthes


The US Federal Trade Commission will require health care giant Johnson & Johnson (NYSE: JNJ) to sell…

Johnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationSynthes

Pfizer updates on plans to spin-off of animal health business


Global drugs behemoth Pfizer (NYSE: PFE) yesterday announced the next steps in the strategic alternatives…

Mergers & AcquisitionsPfizerPharmaceuticalZoetis

OPKO Health to acquire 45% stake in Israeli hepatitis B vaccine maker


Miami, USA-based OPKO Health (NYSE: OPK) has entered into a definitive agreement to acquire a 45% stake…

FDS PharmaMergers & AcquisitionsOPKO HealthPharmaceuticalSci-B-VacSciGenVaccines

Takeda completes URL acquisition which will immediately boost revenues


Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) said yesterday that it has now completed…

ColcrysFinancialMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsURL Pharma

Zacks analysts view progress of GSK bid for Human Genome Sciences


UK pharma giant GlaxoSmithKline (LSE: GSK) recently announced that the waiting period with respect to…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

NicOx drops its option to take full ownership of Altacor


French biotechnology firm NicOx (NYSE Euronext Paris: COX) said last Friday that its board of directors…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmics

UCB buys majority stake in local drugmaker to expand in Brazil


Belgium's leading pharma company UCB (Euronext Brussels: UCB) says it has signed an agreement to acquire…

GenericsMeizler BiopharmaMergers & AcquisitionsPharmaceuticalSouth AmericaUCB

Takeda to acquire Brazil's Multilab for around $249 million


Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, revealed this morning that it has entered…

GenericsMergers & AcquisitionsMultilabPharmaceuticalSouth AmericaTakeda Pharmaceuticals

Israel's Thrombotech and D-Pharm to merge


intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical…

BiotechnologyD-PharmHadasit Bio-HoldingsMergers & AcquisitionsThrombotech

News briefs: GlaxoSmithKline and Bayer


UK pharma giant GlaxoSmithKline (LSE: GSK) has said it would not proceed with its $2.59 billion hostile…

Antibiotics and Infectious diseasesBayerGlaxoSmithKlineMergers & AcquisitionsOncologyPharmaceuticalregorafenibRegulationResearch

Suneva Medical acquires product portfolio from Spear Pharma


Privately-held US aesthetics company Suneva Medical has acquired an aesthetic product portfolio from…

DermatologicalsGenericsMergers & AcquisitionsPharmaceuticalRefissaSpear PharmaceuticalsSuneva MedicalTretinoin

French biotechnology a sector in need of new growth solutions


The biotechnology industry in France is a dynamic sector mainly made up of small structures, but companies…

BiotechnologyEuropeFinancialMergers & Acquisitions

Agilent to acquire cancer diagnostics firm Dako for $2.2 billion


USA-based Agilent Technologies (NYSE: A) and EQT, a Swedish private equity group, have entered into an…

AgilentDakoMergers & AcquisitionsOncologyPharmaceutical

Human Genome adopts Rights Plan to thwart GSK hostile takeover


US biotech company Human Genome Sciences (Nasdaq: HGSI) said yesterday that, after carefully reviewing…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

776 to 800 of 924 results

Back to top